Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
36M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
1.17M
-
Shares change
-
-60.9K
-
Total reported value, excl. options
-
$2.75M
-
Value change
-
-$131K
-
Number of buys
-
4
-
Number of sells
-
-4
-
Price
-
$2.35
Significant Holders of RenovoRx, Inc. - Common Stock (RNXT) as of Q4 2022
13 filings reported holding RNXT - RenovoRx, Inc. - Common Stock as of Q4 2022.
RenovoRx, Inc. - Common Stock (RNXT) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.17M shares
of 36M outstanding shares and own 3.25% of the company stock.
Largest 10 shareholders include BANK OF THE WEST (975K shares), COHEN LAWRENCE B (97.2K shares), GEODE CAPITAL MANAGEMENT, LLC (36.1K shares), COLONY GROUP LLC (15.7K shares), Affinity Capital Advisors, LLC (15.3K shares), Cambridge Investment Research Advisors, Inc. (14.4K shares), VANGUARD GROUP INC (10.9K shares), Tower Research Capital LLC (TRC) (4.12K shares), MORGAN STANLEY (328 shares), and WELLS FARGO & COMPANY/MN (41 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.